跳到正文

Jones Hill Capital LP 13F 持仓 · 2026年Q2

Jones Hill Capital 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 29 只证券,申报市值合计 4.70 亿美元。前几大持仓:BMRN(17.42%)、GILD(9.21%)、ARQT(6.07%)。本季前 25 大持仓中:新建仓 13 只、增持 5 只、减持 7 只。

排名代码公司市值占组合股数变动
1BMRNBIOMARIN PHARMACEUTICAL INC$81.9M17.42%1.4M增持
2GILDGILEAD SCIENCES INC$43.3M9.21%343,043新建仓
3ARQTARCUTIS BIOTHERAPEUTICS INC$28.6M6.07%1.1M新建仓
4MDGLMADRIGAL PHARMACEUTICALS INC$28.2M6.00%52,545新建仓
5BCAXBICARA THERAPEUTICS INC$26.5M5.63%892,621减持
6RLMDRELMADA THERAPEUTICS INC$25.3M5.38%3.7M增持
7TRVITREVI THERAPEUTICS INC$25.0M5.31%1.3M增持
8PHVSPHARVARIS N V$23.4M4.98%677,879增持
9XENEXENON PHARMACEUTICALS INC$22.2M4.72%367,900新建仓
10ANIPANI PHARMACEUTICALS INC$19.4M4.11%233,808减持
11IMCRIMMUNOCORE HLDGS PLC$16.3M3.46%512,856新建仓
12AMLXAMYLYX PHARMACEUTICALS INC$16.1M3.41%894,058减持
13INSMINSMED INC$13.0M2.77%122,375新建仓
14NUVLNUVALENT INC$12.2M2.58%98,442减持
15CAPRCAPRICOR THERAPEUTICS INC$10.1M2.15%420,751减持
16ACRSACLARIS THERAPEUTICS INC$9.3M1.98%1.8M新建仓
17IMUXIMMUNIC INC$8.3M1.76%539,814新建仓
18ORICORIC PHARMACEUTICALS INC$8.1M1.72%747,313新建仓
19TNXPTONIX PHARMACEUTICALS HLDG C$8.0M1.70%625,428增持
20SNDXSYNDAX PHARMACEUTICALS INC$7.4M1.58%340,000新建仓
21OLMAOLEMA PHARMACEUTICALS INC$7.2M1.53%574,166新建仓
22VIRVIR BIOTECHNOLOGY INC$6.7M1.43%659,213减持
23CRBPCORBUS PHARMACEUTICALS HLDGS$6.1M1.30%653,572新建仓
24DNTHDIANTHUS THERAPEUTICS INC$5.6M1.18%57,100新建仓
25VRTXVERTEX PHARMACEUTICALS INC$5.5M1.17%11,123减持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR